GENE ONLINE|News &
Opinion
Blog

COVID-19
Novavax, Takeda, and BMS To Cut Employees This Year
2023-05-10
The U.S. COVID-19 Public Health Emergency Ends in May, but FDA’s EUA Authority Remains
2023-02-01
Novavax Begins Phase 2 For COVID-19/Influenza Combination And Stand-Alone Flu Shots
2023-01-03
CDC Warns Of “Tripledemic” Winter Amid Rising Flu And RSV Cases
2022-11-14
Sanofi, GSK Secure European COVID-19 Booster Approval, AstraZeneca Withdraws U.S. Application
2022-11-10
AstraZeneca’s COVID-19 Vaccine Finally Wins Full Authorization in the European Union
2022-11-01
Pfizer to Raise COVID-19 Vaccine Prices Amidst Rising Flu Cases
2022-10-24
Pfizer/BioNTech’s Omicron Booster Snags Another FDA Emergency Use Authorization
2022-10-12
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants
2022-10-12
Pfizer Pledges 6 million COVID-19 Treatment Courses to Global Fund
2022-09-22
AstraZeneca’s Treatment for COVID-19 Wins European Approval
2022-09-20
The COVID-19 Pandemic: Is Omicron the Last Variant?
2022-09-16
WHO Urges Action After Model Suggests Over 17 Million Europeans Experienced Long COVID
2022-09-14
U.S. Government to No Longer Provide Free COVID-19 Vaccines
2022-08-31
FDA Approves Both Moderna’s and Pfizer/BioNTech’s Omicron Bivalent Vaccines in One Day
2022-08-31
1 2 3 26
LATEST
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scroll to Top